Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ronit Rosenfeld and Adva Mechaly.
Ronit Rosenfeld
Connection Strength
1.467
Adva Mechaly
  1. The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants. Cell Rep. 2021 09 07; 36(10):109679.
    View in: PubMed
    Score: 0.241
  2. Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1. J Infect Dis. 2021 08 16; 224(4):616-619.
    View in: PubMed
    Score: 0.241
  3. Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice. iScience. 2021 May 21; 24(5):102479.
    View in: PubMed
    Score: 0.235
  4. Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimens. Anal Bioanal Chem. 2021 May; 413(13):3501-3510.
    View in: PubMed
    Score: 0.234
  5. Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody. Nat Commun. 2021 02 11; 12(1):944.
    View in: PubMed
    Score: 0.232
  6. A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes. Nat Commun. 2020 08 27; 11(1):4303.
    View in: PubMed
    Score: 0.225
  7. Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope. Viruses. 2021 03 26; 13(4).
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.